NF‐κB, a central regulator of inflammation in ALI, promotes inflammatory gene expression upon its activation, which involves p65 phosphorylation and nuclear translocation, making it a significant pharmacological target (Cheng et al. 2024). Here, NFKB1 is linked to acute respiratory distress syndrome.